Mallinckrodt Acthar Gel phase IV clinical study with relapsing multiple sclerosis

STAINES-UPON-THAMES, United Kingdom Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4...

A U.S. Food and Drug Administration (FDA) review to date has not identified adverse...

A U.S. Food and Drug Administration (FDA) review to date has not identified adverse health effects from gadolinium retained in the brain after the...

Roche seeks partners for remyelination therapies

Roche Holding AG is seeking a partner with experimental drugs that might help repair the damage caused to the nervous system by multiple sclerosis...

Celgene announces data on its phase III relapsing MS Ozanimod experimental treatment

Study met the primary endpoint of annualized relapse rate (ARR) and key secondary MRI endpoints of T2 and GdE lesions, compared to interferon (IFN)...
video

Talking about Ocrevus (Ocrelizumab)

The Rocky Mountain Multiple Sclerosis Center is a patient and family-centered nonprofit organization that provides a comprehensive and integrated wellness approach to MS and...

Using Statin’s in multiple sclerosis treatment

Scientists are hopeful a major drug trial will establish that statins can be used to treat multiple sclerosis.The low-cost drugs are typically prescribed to...

Social Media

683FollowersFollow